193
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Solid super saturated self-nanoemulsifying drug delivery system (sat-SNEDDS) as a promising alternative to conventional SNEDDS for improvement rosuvastatin calcium oral bioavailability

&
Pages 1513-1521 | Received 18 Feb 2016, Accepted 11 Aug 2016, Published online: 26 Aug 2016

References

  • Ranchhodbhai Patel H, Manordas Patel M. Development of osmotically controlled mucoadhesive Cup-Core (OCMC) tablet for the anti-inflammatory activity. Iran J Pharm Res. 2010;9:21–26.
  • Lindgren S, Janzon L. Prevalence of swallowing complaints and clinical findings among 50–79-year-old men and women in an urban population. Dysphagia. 1991;6:187–192.
  • Inugala S, Eedara BB, Sunkavalli S, et al. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: in vitro and in vivo evaluation. Eur J Pharm Sci. 2015;10:1–10.
  • Williams HD, Trevaskis NL, Charman SA, et al. Strategies to address low drug solubility in discovery and development. Pharmacol Rev. 2013;65:315–499.
  • Dash RN, Mohammed H, Humaira T, et al. Design, optimization and evaluation of glipizide solid self-nanoemulsifying drug delivery for enhanced solubility and dissolution. Saudi Pharm J. 2015;23:528–540.
  • Trivedi K, Patel PV, Pujara Z. Development and characterization of liquid and solid self-emulsifying drug delivery system of fexofenadine. J Pharm Investig. 2013;43:385–394.
  • Porter CJ, Kaukonen AM, Taillardat-Bertschinger A, et al. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. J Pharm Sci. 2004;93:1110–1121.
  • Bevernage J, Forier T, Brouwers J, et al. Excipient-mediated supersaturation stabilization in human intestinal fluids. Mol Pharm. 2011;8:564–570.
  • Bevernage J, Brouwers J, Clarysse S, et al. Drug supersaturation in simulated and human intestinal fluids representing different nutritional states. J Pharm Sci. 2010;99:4525–4534.
  • Yeom DW, Son HY, Kim JH, et al. Development of a solidified self-microemulsifying drug delivery system (S-SMEDDS) for atorvastatin calcium with improved dissolution and bioavailability. Int J Pharm. 2016;506:302–311.
  • Balakrishnan P, Lee BJ, Oh DH, et al. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm. 2009;72:539–545.
  • Seo YG, Kim DW, Yousaf AM, et al. Solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced oral bioavailability of poorly water-soluble tacrolimus: physicochemical characterisation and pharmacokinetics. J Microencapsul. 2015;32:503–510.
  • Nokhodchi A, Hentzschel CM, Leopold CS. Drug release from liquisolid systems: speed it up, slow it down. Expert Opin Drug Del. 2011;8:191–205.
  • Seo YG, Kim DH, Ramasamy T, et al. Development of docetaxel-loaded solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced chemotherapeutic effect. Int J Pharm. 2013;452:412–420.
  • Vraníková B, Gajdziok J. Liquisolid systems and aspects influencing their research and development. Acta Pharm. 2013;63:447–465.
  • Shafiq S, Shakeel F, Talegaonkar S, et al. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007;66:227–243.
  • Parveen R, Baboota S, Ali J, et al. Oil based nanocarrier for improved oral delivery of silymarin: in vitro and in vivo studies. Int J Pharm. 2011;413:245–253.
  • Jeyaraj S, Shivaji G, Jeyaraj SD, et al. Effect of combined supplementation of fish oil with garlic pearls on the serum lipid profile in hypercholesterolemic subjects. Indian Heart J. 2005;57:327–331.
  • Eilertsen KE, Mæhre HK, Cludts K, et al. Dietary enrichment of apolipoprotein E-deficient mice with extra virgin olive oil in combination with seal oil inhibits atherogenesis. Lipids Health Dis. 2011;10:41.
  • Abo Enin HA. Self-nanoemulsifying drug-delivery system for improved oral bioavailability of rosuvastatin using natural oil antihyperlipdemic. Drug Dev Ind Pharm. 2015;41:1047–1056.
  • Ren L, Zhou Y, Wei P, et al. Preparation and pharmacokinetic study of aprepitant-sulfobutyl ether-β-cyclodextrin complex. AAPS PharmSciTech. 2014;15:121–130.
  • Shakeel F, Alanazi F, Alsarra I, et al. Solubility prediction of indomethacin in PEG 400+water mixtures at various temperatures. J Mol Liq. 2013;188:28–32.
  • Thomas N, Holm R, Garmer M, et al. Supersaturated self-nanoemulsifying drug delivery systems (Super-SNEDDS) enhance the bioavailability of the poorly water-soluble drug simvastatin in dogs. AAPS J. 2012;15:219–227.
  • Badran M, Taha E, Tayel M, et al. Ultra-fine self nanoemulsifying drug delivery system for transdermal delivery of meloxicam: dependency on the type of surfactants. J Mol Liq. 2014;190:16–22.
  • Taha EI, Al-Saidan S, Samy AM, et al. Preparation and in vitro characterization of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Int J Pharm. 2004;285:109–119.
  • Al-Achi A, Patel B. Formulation and optimization of potassium iodide tablets Saudi. Pharm J. 2015;23:95–101.
  • Wei Y, Ye X, Shang X, et al. Enhanced oral bioavailability of silybin by a supersaturatable self-emulsifying drug delivery system (S-SEDDS). Colloids Surf A: Physicochem Eng Asp. 2012;396:22–28.
  • Elkasabgy NA. Ocular supersaturated self-nanoemulsifying drug delivery systems (S-SNEDDS) to enhance econazole nitrate bioavailability. Int J Pharm. 2014;460:33–44.
  • Baek MK, Lee JH, Cho YH, et al. Self-microemulsifying drug-delivery system for improved oral bioavailability of pranlukast hemihydrate: preparation and evaluation. Int J Nanomedicine. 2013;8:167–176.
  • Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm. 2010;391:203–211.
  • Balakumar K, Raghavan CV, Selvan NT, et al. Self nanoemulsifying drug delivery system (SNEDDS) of Rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation. Colloids Surf B Biointerfaces. 2013;112:337–343.
  • Kaila HO, Ambasana MA, Thakkar RS, et al. A new improved RP-HPLC method for assay of rosuvastatin calcium in tablets. Indian J Pharma Sci. 2010;72:592–598.
  • Galani V, Vyas M. In vivo and in vitro drug interactions study of glimepride with atorvastatin and rosuvastatin. J Young Pharm. 2010;2:196–200.
  • Chhabria MT, Patel VT, Rajan KS, et al. Design, synthesis and histamine H1-receptor antagonistic activity of some novel 4-amino-2-(substituted)-5-(substituted) aryl-6-[(substituted aryl) amino] pyrimidines. Arzneimittelforschung. 2009;59:243–247.
  • Wankhade V, Tapar K, Pande S, et al. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for gliclazide. Der Pharmacia Lettre. 2010;2:132–143.
  • Izquierdo P, Feng J, Esquena J, et al. The influence of surfactant mixing ratio on nano-emulsion formation by the PIT method. J Colloid Interface Sci. 2005;285:388–394.
  • Alzoman NZ, Sultan MA, Maher HM, et al. Analytical study for the charge-transfer complexes of rosuvastatin calcium with π-acceptors. Molecules. 2013;18:7711–7725.
  • Mao S, Sun W, Kissel T. Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev. 2010;62:12–27.
  • Bhimte NA, Tayade PT. Evaluation of microcrystalline cellulose prepared from sisal fibers as a tablet excipient: a technical note. AAPS PharmSciTechnol. 2007;8:E56–E62.
  • Milović M, Simović S, Lošić D, et al. Solid self-emulsifying phospholipid suspension (SSEPS) with diatom as a drug carrier. Eur J Pharm Sci. 2014;63:226–232.
  • Gao P, Rush BD, Pfund WP, et al. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci. 2003;92:2386–2398.
  • Phan S, Salentinig S, Prestidge CA, et al. Self-assembled structures formed during lipid digestion: characterization and implications for oral lipid-based drug delivery systems. Drug Deliv Transl Res. 2014;4:275–294.
  • Sassene P, Kleberg K, Williams HD, et al. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 6: effects of varying pancreatin and calcium levels. AAPS J. 2014;16:1344–1357.
  • Gao P, Morozowich W. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv. 2006;3:97–110.
  • Anby MU, Williams HD, McIntosh M, et al. Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilisation on the in vitro and in vivo performance of self-emulsifying drug delivery systems. Mol Pharm. 2012;9:2063–2079.
  • Fotaki N, Long CM, Tang K, et al. Dissolution of amorphous solid dispersions: theory and practice. In: Shah N, editor. Amorphous solid dispersions, advances in delivery science and technology. New York: Springer; 2014. p. 492–496.
  • Oh DH, Kang JH, Kim DW, et al. Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier. Int J Pharm. 2011;420:412–418.
  • Chamsai B, Sriamornsak P. Novel disintegrating microcrystalline cellulose pellets with improved drug dissolution performance. Powder Technol. 2013;233:278–285.
  • Raijada D, Cornett C, Rantanen J. A high throughput platform for understanding the influence of excipients on physical and chemical stability. Int J Pharm. 2013;453:285–292.
  • Ardizzone S, Dioguardi FS, Mussini T, et al. Microcrystalline cellulose powders: structure, surface features and water sorption capability. Cellulose. 1999;6:57–69.
  • Spence JK, Bhattachar SN, Wesley JA, et al. Increased dissolution rate and bioavailability through comicronization with microcrystalline cellulose. Pharm Dev Technol. 2005;10:451–460.
  • Jeevana JB, Sreelakshmi K. Design and evaluation of self nanoemulsifying drug delivery system of flutamide. J Young Pharm. 2011;3:4–8.
  • Cherniakov I, Domb AJ, Hoffman A. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects. Expert Opin Drug Deliv. 2015;12:1121–1133.
  • Carstens MG, Rijcken CJF, van Nostrum CF, et al. Pharmaceutical micelles: combining longevity, stability, and stimuli sensitivity. In: Vladimir T, editor. Multifunctional pharmaceutical nanocarriers. Vol. 4. New York: Springer; 2008. p. 263–308.
  • Hussain R, Kudo T, Tsujikawa T, et al. Validation of the calculation of the clearance rate constant (kmono) of [(11)C] acetate using parametric k(mono) image for myocardial oxidative metabolism. Nucl Med Biol. 2009;36:877–882.
  • Zhang Y, Benet LZ. The gut as a barrier to drug absorption combined role of cytochrome P450 3A and P-glycoprotein. Clin Pharmacokinet. 2001;40:159–168.
  • Seeballuck F, Ashford MB, O’Driscoll CM. The effects of pluronic block copolymers and cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells. Pharm Res. 2003;20:1085–1092.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.